Primary Treatment of Kawasaki Disease with Corticosteroids
Kawasaki disease (KD), is the leading cause of acquired heart disease in children in the developed world. The use of aspirin and intravenous immunoglobulin as the initial therapy in KD is the standard of care, as they reduce the incidence of coronary artery aneurysms, the major cardiac morbidity f...
Main Authors: | Swati Singhal, Devendra Mishra, Sumod Kurien, Monica Juneja |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2014-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/4366/7076_191213_7076_CE[Ra]_PF1(PAK)_PFA(H)_E(V)_PF2(PAG)_PF2(PN).pdf |
Similar Items
-
Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease
by: Chun-Na Zhao, et al.
Published: (2016-01-01) -
Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
by: Abdolkarim Hamedi, et al.
Published: (2017-08-01) -
The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
by: Tsung-Ju Yang, et al.
Published: (2018-06-01) -
Missed Kawasaki disease in childhood presenting as myocardial infarction in adults
by: Ajit Bhagwat, et al.
Published: (2015-07-01) -
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
by: Kevin G. Friedman, et al.
Published: (2016-09-01)